MEDICAMEN BIOTECH LTD. (MEDICAMEQ)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 38.67 41.94 43.54 46.50 47.32 43.05 44.74 45.14 29.61 43.04 47.17 46.91
YOY Revenue Growth % 69.93% 26.76% 29.85% 30.69% 22.38% 2.64% 2.76% -2.92% -37.42% -0.01% 5.42% 3.91%
Other Income 0.35 0.38 0.55 0.83 0.57 0.59 0.29 0.14 5.23 0.47 0.37 0.53
Total Income 39.01 42.32 44.09 47.33 47.89 43.63 45.03 45.28 34.84 43.52 47.54 47.44
Total Expenses + 32.69 40.23 43.41 45.72 39.80 37.18 43.93 44.64 32.35 41.38 44.86 45.33
Cost of Materials Consumed 22.16 26.11 27.67 29.10 21.82 21.67 28.94 28.52 11.52 24.60 21.97 21.69
Employee Benefit Expense 5.52 6.56 7.10 8.01 8.39 7.84 7.63 8.00 8.40 8.09 8.83 8.37
Other Expenses 5.01 7.56 8.65 8.62 9.58 7.68 7.35 8.11 9.06 7.63 10.03 10.45
Operating Profit 5.98 1.71 0.13 0.78 7.52 5.87 0.81 0.50 -2.74 1.66 2.31 1.58
OPM % 15.5% 4.1% 0.3% 1.7% 15.9% 13.6% 1.8% 1.1% -9.2% 3.9% 4.9% 3.4%
Profit Before Tax + 4.36 4.68 2.46 3.27 2.66 1.56 1.96 3.88 2.49 2.13 2.68 2.11
Tax Expense 0.59 0.74 0.99 1.24 0.62 0.76 1.05 0.95 0.63 0.53 0.57 0.48
Tax % 13.5% 15.7% 40.1% 38% 23.2% 48.7% 53.8% 24.6% 25.2% 24.9% 21.2% 22.6%
Profit After Tax 3.77 3.95 1.48 2.03 2.04 0.80 0.90 2.92 1.86 1.60 2.11 1.63
EPS (Basic) 3.03 3.12 1.17 1.60 1.61 0.63 0.71 2.30 1.47 1.18 1.56 1.21

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 162.55 179.31 140.87 115.45
YOY Revenue Growth % -9.35% 27.29% 22.02% -
Other Income 6.24 2.33 2.46 1.72
Total Income 168.79 181.63 143.33 117.17
Total Expenses + 158.91 169.17 126.70 95.24
Cost of Materials Consumed 90.65 104.70 81.80 55.69
Employee Benefit Expense 31.87 30.07 20.44 14.50
Other Expenses 32.20 34.40 24.46 25.04
Operating Profit 3.64 10.14 14.16 20.21
OPM % 2.2% 5.7% 10.1% 17.5%
Profit Before Exceptional 9.88 13.08 17.05 18.09
Exceptional Items 0.00 0.00 0.00 0.00
Profit Before Tax + 9.88 13.08 17.05 18.09
Tax Expense 3.32 3.58 2.32 3.20
Tax % 33.6% 27.4% 13.6% 17.7%
Profit After Tax 6.56 9.49 14.73 14.90
EPS (Basic) 5.16 7.50 11.82 12.19

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 132.33 134.93 115.15 0.00
Property, Plant & Equipment 86.12 90.95 91.76 0.00
Capital Work in Progress 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 0.74 0.90 0.90 0.00
Current Assets + 164.55 159.59 163.36 0.00
Inventories 62.14 59.38 45.06 0.00
Trade Receivables 68.90 55.26 65.26 0.00
Cash and Cash Equivalents 3.76 14.79 20.78 0.00
Current Investments 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00
Equity Share Capital 12.71 12.71 12.65 0.00
Other Equity 200.07 187.77 180.76 0.00
Non-Current Liabilities 5.94 3.01 2.53 0.00
Current Liabilities 78.17 91.03 82.57 0.00
Total Liabilities 84.10 94.04 85.10 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities -7.19 -0.37 -6.29 4.11
Cash from Investing Activities -1.89 -5.56 -5.88 -8.47
Cash from Financing Activities -1.94 -0.06 29.13 4.30
Net Increase/Decrease in Cash -11.02 -5.99 16.95 -0.07